Analyses of the skin molecules in the patient of atopic dermatitis.
- Conditions
- Atopic dermatitis
- Registration Number
- JPRN-UMIN000027285
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 30
Not provided
1.Panelists who use the steroid and immunosuppressant in face for more than 2 weeks during a month. 2.Panelists who used the antibiotics in the last 2 weeks. 3.Panelists who have the disease, such as diabetes, affecting on this study. 4.Panelists who use the drugs affecting on this study. 5.Panelists who have undergone some beauty treatments on their faces. 6.Panelists participating in, or scheduled to participate in, another study during the study period. 7.Panelists who smoke.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The relationship between skin molecules and status of atopic dermatitis.
- Secondary Outcome Measures
Name Time Method The relationship between skin molecules and questionnaires.